AssayIndex
Reports by quarter

Reports submitted in 2025-Q2 · page 12

Gravimetric mass-balance reconciliation became mandatory on new records. Median purity for the quarter is 99.05 % area, n=619. Read the 2025-Q2 state-of-the-index report →

619 records16 pagesmedian on this page 99.30 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020058RetatrutideSWBSWB-2503-P7565Medutest2025-Q298.755.08—Buyer-sourced1MARGINAL
AX-2025-019701ARA-290TFCTFC-2501-K2935Janoshik2025-Q299.825.1190.6Buyer-sourced0PASS
AX-2025-019549VIPTFCTFC-2503-E9984Medutest2025-Q299.283.9289.6Buyer-sourced1MARGINAL
AX-2025-019185BPC-157SinoPepSNP-2501-E3910Medutest2025-Q299.654.08—Buyer-sourced0PASS
AX-2025-018618GHRP-6QYBQYB-2504-H5023Janoshik2025-Q299.046.53—Buyer-sourced0PASS
AX-2025-021205TirzepatidePPGPPG-2503-R7317Janoshik2025-Q299.334.2293.4Laboratory-retained0PASS
AX-2025-021061TirzepatideBCHBCH-2501-D4197Janoshik2025-Q297.004.10101.2Buyer-sourced0PASS
AX-2025-020443SemaxKPKP-2502-H5248Janoshik2025-Q299.046.59—Buyer-sourced0PASS
AX-2025-020420KPVMKMMKM-2504-N4868Janoshik2025-Q299.665.0893.8Buyer-sourced0FAIL
AX-2025-019979TirzepatideHJHJ-2505-H6642Janoshik2025-Q298.874.99102.2Buyer-sourced0PASS
AX-2025-019381MK-677 (Ibutamoren mesylate)HYBHYB-2505-M6859Kestrel2025-Q299.934.30—Buyer-sourced1FAIL
AX-2025-019210TirzepatideSinoPepSNP-2502-X4903VendorInvestigate2025-Q298.466.1398.1Buyer-sourced0PASS
AX-2025-018905CJC-1295 with DACTFSTFS-{CAT}-1220Janoshik2025-Q298.724.16105.3Buyer-sourced1MARGINAL
AX-2025-018777GHRP-6FGPFGP-2411-J8288PeptideMeter2025-Q299.936.07—Buyer-sourced0PASS
AX-2025-018428NAD+WWBWWB-2504-B2388Janoshik2025-Q299.3711.04100.0Buyer-sourced0FAIL
AX-2025-0208905-Amino-1MQWXTWXT-2505-M2430Medutest2025-Q298.272.90100.5Buyer-sourced0FAIL
AX-2025-020866MK-677 (Ibutamoren mesylate)CPCCPC-2503-G2382Janoshik2025-Q298.785.55—Buyer-sourced1FAIL
AX-2025-020765TirzepatideSGNSGN-2503-P9641PeptideMeter2025-Q297.993.55—Supplier-supplied1MARGINAL
AX-2025-020392SurvodutideMKMMKM-2411-E4057Janoshik2025-Q297.884.9594.2Buyer-sourced1FAIL
AX-2025-019341DihexaHYBHYB-2501-T6290Janoshik2025-Q299.487.2693.6Buyer-sourced0PASS
AX-2025-021157IpamorelinPPGPPG-2505-U7155Janoshik2025-Q299.813.86103.8Buyer-sourced0PASS
AX-2025-020701CJC-1295 (no DAC)SGNSGN-2412-L9210Janoshik2025-Q299.364.89—Buyer-sourced0PASS
AX-2025-020432TB-500KPKP-2412-H5186Janoshik2025-Q299.204.2197.5Buyer-sourced0PASS
AX-2025-020050RetatrutideSWBSWB-2503-P7565Janoshik2025-Q298.174.9799.9Buyer-sourced1MARGINAL
AX-2025-020013N-Acetyl Semax AmideSWBSWB-2504-W7050PeptideMeter2025-Q299.409.88106.8Buyer-sourced0PASS
AX-2025-019982TirzepatideHJHJ-2505-H6642Janoshik2025-Q298.534.9991.7Buyer-sourced0PASS
AX-2025-019073AOD-9604GSPGSP-2411-L2462Janoshik2025-Q298.954.99106.7Buyer-sourced0PASS
AX-2025-019051Thymosin α1ASYASY-{CAT}-2031PeptideMeter2025-Q299.374.20—Buyer-sourced0PASS
AX-2025-018838TirzepatideFGPFGP-2412-N8628Kestrel2025-Q299.034.64—Buyer-sourced0PASS
AX-2025-018702TB-500QSCQSC-2504-T6759PeptideMeter2025-Q299.844.04105.0Buyer-sourced1MARGINAL
AX-2025-018572SelankQYBQYB-2501-T4869PeptideMeter2025-Q299.937.33—Buyer-sourced0PASS
AX-2025-021203TirzepatidePPGPPG-2503-R7317Janoshik2025-Q299.324.23—Buyer-sourced1FAIL
AX-2025-021191Thymosin α1PPGPPG-2501-D6869Janoshik2025-Q299.663.8397.7Supplier-supplied2MARGINAL
AX-2025-021153IpamorelinPPGPPG-2505-U7155Janoshik2025-Q299.664.8589.3Buyer-sourced1MARGINAL
AX-2025-021143GHK-CuSIGSIG-2503-6560PeptideMeter2025-Q298.286.2592.0Buyer-sourced0PASS
AX-2025-0208865-Amino-1MQWXTWXT-2505-M2430Nordanalyt2025-Q299.342.7798.0Supplier-supplied0FAIL
AX-2025-020327BPC-157GGPepsGGPE-2411-V3137Kestrel2025-Q299.343.3891.1Buyer-sourced0PASS
AX-2025-020286NAD+GGPepsGGPE-2502-W2287PeptideMeter2025-Q298.6511.8997.4Buyer-sourced1FAIL
AX-2025-020057RetatrutideSWBSWB-2503-P7565Kestrel2025-Q298.824.99—Buyer-sourced2FAIL
AX-2025-019813SemaglutideHomopeptideHOMO-2501-A5192Janoshik2025-Q299.526.29—Buyer-sourced0PASS